Search Results - "Kohanbash G"

Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome.

Authors: Golbourn BJ Halbert ME Halligan K et al.

Source: Nature cancer [Nat Cancer] 2022 Jul; Vol. 3 (7), pp. 899.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE; PubMed not MEDLINE

EGFR-targeted affibody–polyIC polyplex kills EGFR-overexpressing cancer cells without activating the EGFR.

Authors: Pettikiriarachchi, Anne Ugolev, Yelena Birkinshaw, Richard et al.

Source: PLoS ONE. 5/5/2026, Vol. 21 Issue 5, p1-28. 28p.

Microbial production of short-chain fatty acids attenuates long-term neurologic impairment after traumatic brain injury.

Authors: Xiong Z Dodson BP Rogers MB et al.

Source: Journal of neuroinflammation [J Neuroinflammation] 2025 Dec 09; Vol. 22 (1), pp. 285. Date of Electronic Publication: 2025 Dec 09.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101222974 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-2094 (Electronic) Linking ISSN: 17422094 NLM ISO Abbreviation: J Neuroinflammation Subsets: MEDLINE

PTPN11-related Noonan syndrome predisposes to multifocal low-grade CNS tumors harboring FGFR1 variants.

Authors: Kohanbash G Ryall S Gary SE et al.

Source: Journal of neuro-oncology [J Neurooncol] 2026 Mar 05; Vol. 177 (1). Date of Electronic Publication: 2026 Mar 05.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

Reprogramming the Immunosuppressive Microenvironment in Glioblastoma Through Oncolytic Herpes Simplex Virus Therapy: A Systematic Review.

Authors: Poboży, Kamil Ząbek, Zuzanna Turek, Grzegorz et al.

Source: Cells (2073-4409). May2026, Vol. 15 Issue 10, p867. 31p.

C/EBPβ-induced alternative splicing of RCAN1 generates a potent TCR-T target in mesenchymal glioblastoma.

Authors: Xiong Z Kong Q Chagantipati B et al.

Source: Cellular & molecular immunology [Cell Mol Immunol] 2026 Jan; Vol. 23 (1), pp. 94-113. Date of Electronic Publication: 2025 Dec 23.

Publication Type: Journal Article

Journal Info: Publisher: Chinese Society of Immunology Country of Publication: China NLM ID: 101242872 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-0226 (Electronic) Linking ISSN: 16727681 NLM ISO Abbreviation: Cell Mol Immunol Subsets: MEDLINE

Preclinical Evaluation of an Anti-EphA2 Minibody-Based ImmunoPET Agent as a Diagnostic Tool For Cancer.

Authors: Birikorang PA Wedaarachchi HEG Smith JA et al.

Source: Molecular imaging and biology [Mol Imaging Biol] 2025 Dec; Vol. 27 (6), pp. 993-1005. Date of Electronic Publication: 2025 Sep 19.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101125610 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-2002 (Electronic) Linking ISSN: 15361632 NLM ISO Abbreviation: Mol Imaging Biol Subsets: MEDLINE

Molecular Determinants of Macrophage Polarization in Glioblastoma and Implications for Tumor Progression.

Authors: Luo, Xiao-Xiao Fu, Min Zhao, Ben et al.

Source: Cells (2073-4409). Mar2026, Vol. 15 Issue 6, p508. 19p.

The Many Faces of Glioblastoma-Associated Macrophages and Their Gene Signatures.

Authors: Lindström, Mikael S.¹ (AUTHOR)

Source: Cancers. Feb2026, Vol. 18 Issue 4, p624. 6p.

Transcript-targeted antigen mapping reveals the potential of POSTN splicing junction epitopes in glioblastoma immunotherapy.

Authors: Xiong Z Sneiderman CT Kuminkoski CR et al.

Source: Genes and immunity [Genes Immun] 2025 Jun; Vol. 26 (3), pp. 190-199. Date of Electronic Publication: 2025 Apr 03.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 100953417 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5470 (Electronic) Linking ISSN: 14664879 NLM ISO Abbreviation: Genes Immun Subsets: MEDLINE

Single-cell transcriptomics reveals immunosuppressive microenvironment and highlights tumor-promoting macrophage cells in Glioblastoma.

Authors: Cheng, Han Yan, Yan Zhang, Biao et al.

Source: PLoS ONE. 4/7/2025, Vol. 20 Issue 4, p1-19. 19p.

Role of Scar‐Associated Macrophages in Organ Fibrosis Diseases.

Authors: Ding, Runmin Yang, Zexin Chen, Yuxi et al.

Source: Journal of Immunology Research. 1/28/2026, Vol. 2026, p1-11. 11p.

Targeted Inhibition of Oncogenic microRNAs miR-21, miR-17, and miR-155 Suppresses Tumor Growth and Modulates Immune Response in Colorectal Cancer.

Authors: Patutina, Olga Sen'kova, Aleksandra Miroshnichenko, Svetlana et al.

Source: Pharmaceutics. Jan2026, Vol. 18 Issue 1, p122. 27p.

Innovative In Vivo Imaging and Single Cell Expression from Tumor Bulk and Corpus Callosum Reveal Glioma Stem Cells with Unique Regulatory Programs.

Authors: dos Santos, Natalia Aquino, Aline Preußer, Friedrich et al.

Source: Cancers. Dec2025, Vol. 17 Issue 23, p3851. 21p.

Assessing brain metastasis response to immunotherapy: a pictorial review of atypical responses and intracranial adverse events.

Authors: Amseian, Gary Aya, Francisco Pineda, Camilo et al.

Source: Insights into Imaging. 11/19/2025, Vol. 16 Issue 1, p1-18. 18p.

Immune Scenario Identification Combining Multiplexed, Quantitative, and Advanced Imaging Analysis Could Be Relevant in Immunotherapy against Glioblastoma and Grade 4 Astrocytoma.

Authors: Idoate, Miguel A. Ariz-Galilea, Mikel Urbiola-Casales, Ainhoa et al.

Source: Pathobiology. 2025, Vol. 92 Issue 6, p315-334. 20p.

Myeloid cells as potential targets for immunotherapy in pediatric gliomas.

Authors: Frederico SC Sharma N Darling C et al.

Source: Frontiers in pediatrics [Front Pediatr] 2024 Mar 08; Vol. 12, pp. 1346493. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101615492 Publication Model: eCollection Cited Medium: Print ISSN: 2296-2360 (Print) Linking ISSN: 22962360 NLM ISO Abbreviation: Front Pediatr Subsets: PubMed not MEDLINE

In Vivo CAR-Based Immune Cell Engineering: Future Applications and Challenges in Malignant Glioma.

Authors: Yamaguchi, Junya Bergquist, Alejandra Lu, Jianwen et al.

Source: Cancers. Jun2026, Vol. 18 Issue 12, p1986. 32p.

Myeloid-Derived Suppressor Cells: Function, Migration, and Therapeutic Opportunities in Glioblastoma.

Authors: Figg, John W. Love, Caitland West, Illeana et al.

Source: Cells (2073-4409). Jun2026, Vol. 15 Issue 12, p1099. 18p.

Poly(I:C) Lipoamino Bundle LNPs Induce Tumor Cytotoxicity and Immune Activation with Enhanced Efficacy by Survivin Silencing.

Authors: Yazdi, Mina Hasheminejad, Zahra Hachani, Khouloud et al.

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 11, p4968. 23p.